Gert van Valkenhoef

5.3k citations

33 papers · 2.6k indexed · 2 hit papers · h-index 20

Surgery top 5%
Pulmonary and Respiratory Medicine top 10%
Cardiology and Cardiovascular Medicine top 5%
Statistics, Probability and Uncertainty top 0.5%
Statistics and Probability top 1%

Co-authors: A. E. Ades Hans L. Hillege Nicky J. Welton Bert de Brock Tommi Tervonen Sofia Dias Guobing Lu Douwe Postmus
Topics: Meta-analysis and systematic reviews (11 papers)Statistical Methods in Clinical Trials (9 papers)Health Systems, Economic Evaluations, Quality of Life (8 papers)
Cited by: Statistics, Probability and Uncertainty Statistics and Probability Cardiology and Cardiovascular Medicine
Journals: Journal of the American College of Cardiology JNCI Journal of the National Cancer Institute Scientific Reports
Partner nations: Netherlands United Kingdom United States

In The Last Decade

Gert van Valkenhoef

32 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Automating network meta‐analysis

2012 577 citations Gert van Valkenhoef, Bert de Brock et al. Research Synthesis Methods profile →
Automated generation of node‐splitting models for assessment of inconsistency in network meta‐analysis

2015 446 citations Gert van Valkenhoef, Sofia Dias et al. Research Synthesis Methods profile →

Peers

Countries citing papers authored by Gert van Valkenhoef

Since Specialization

Citations

This map shows the geographic impact of Gert van Valkenhoef's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gert van Valkenhoef with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gert van Valkenhoef more than expected).

Fields of papers citing papers by Gert van Valkenhoef

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gert van Valkenhoef. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gert van Valkenhoef. The network helps show where Gert van Valkenhoef may publish in the future.

Co-authorship network of co-authors of Gert van Valkenhoef

This figure shows the co-authorship network connecting the top 25 collaborators of Gert van Valkenhoef. A scholar is included among the top collaborators of Gert van Valkenhoef based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gert van Valkenhoef. Gert van Valkenhoef is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Capecitabine, 5-fluorouracil and S-1 based regimens for previously untreated advanced oesophagogastric cancer: A network meta-analysis 2017 ·Scientific Reports ·Emil ter Veer,Lok Lam Ngai,Gert van Valkenhoef,Nadia Haj Mohammad,Maarten Anderegg,Martijn G.H. van Oijen,Hanneke W.M. van Laarhoven	20
2	Individual Trade-Offs Between Possible Benefits and Risks of Cancer Treatments: Results from a Stated Preference Study with Patients with Multiple Myeloma 2017 ·The Oncologist ·Douwe Postmus,(unknown),Nathalie Bere,Gert van Valkenhoef,(unknown),Eric Low,(unknown),Maria Mavris,(unknown),(unknown),Hans L. Hillege,Francesco Pignatti	43
3	GetReal in network meta‐analysis: a review of the methodology 2016 ·Research Synthesis Methods ·Orestis Efthimiou,Thomas P. A. Debray,Gert van Valkenhoef,Sven Trelle,(unknown),Karel G.M. Moons,Johannes B. Reitsma,Aijing Shang,Georgia Salanti,(unknown)	268
4	Second- and third-line systemic therapy in patients with advanced esophagogastric cancer: a systematic review of the literature 2016 ·Cancer and Metastasis Reviews ·Emil ter Veer,Nadia Haj Mohammad,Gert van Valkenhoef,Lok Lam Ngai,(unknown),Martijn G.H. van Oijen,Hanneke W.M. van Laarhoven	32
5	Previously unidentified duplicate registrations of clinical trials: an exploratory analysis of registry data worldwide 2016 ·Systematic Reviews ·Gert van Valkenhoef,Russell F. Loane,Deborah A. Zarin	19
6	The Efficacy and Safety of First-line Chemotherapy in Advanced Esophagogastric Cancer: A Network Meta-analysis 2016 ·JNCI Journal of the National Cancer Institute ·Emil ter Veer,Nadia Haj Mohammad,Gert van Valkenhoef,Lok Lam Ngai,(unknown),Maarten Anderegg,Martijn G.H. van Oijen,Hanneke W.M. van Laarhoven	86
7	Automated generation of node‐splitting models for assessment of inconsistency in network meta‐analysisbreakdown → 2015 ·Research Synthesis Methods ·Gert van Valkenhoef,Sofia Dias,A. E. Ades,Nicky J. Welton	446
8	Evaluation of CADD Scores in Curated Mismatch Repair Gene Variants Yields a Model for Clinical Validation and Prioritization 2015 ·Human Mutation ·K. Joeri van der Velde,Joël Kuiper,Bryony A. Thompson,John‐Paul Plazzer,Gert van Valkenhoef,Mark de Haan,Jan D.H. Jongbloed,Cisca Wijmenga,Tom J. de Koning,Kristin M. Abbott,Richard J. Sinke,Amanda B. Spurdle,Finlay Macrae,Maurizio Genuardi,Rolf H. Sijmons,Morris A. Swertz,(unknown)	29
9	Crowdsourcing a Comprehensive Clinical Trial Repository 2014 ·University of Groningen research database (University of Groningen / Centre for Information Technology) ·Gert van Valkenhoef,Joël Kuiper	2
10	Evidence-Based Prescribing 2014 ·Circulation Cardiovascular Quality and Outcomes ·Huseyin Naci,Gert van Valkenhoef,Julian P. T. Higgins,Rachael Fleurence,A. E. Ades	23
11	A mixed treatment comparison of gabapentin enacarbil, pramipexole, ropinirole and rotigotine in moderate-to-severe restless legs syndrome 2014 ·Current Medical Research and Opinion ·Ying Sun,Gert van Valkenhoef,Thomas Morel	12
12	A multi-criteria decision analysis perspective on the health economic evaluation of medical interventions 2013 ·The European Journal of Health Economics ·Douwe Postmus,Tommi Tervonen,Gert van Valkenhoef,Hans L. Hillege,Erik Buskens	14
13	ADDIS: an automated way to do network meta-analysis 2012 ·University of Groningen research database (University of Groningen / Centre for Information Technology) ·Jing Zhao,Gert van Valkenhoef,(unknown),Hans L. Hillege	10
14	Clinical trials information in drug development and regulation: existing systems and standards 2012 ·Gert van Valkenhoef,Tommi Tervonen,Bert de Brock,Hans L. Hillege	19
15	Deficiencies in the transfer and availability of clinical trials evidence: a review of existing systems and standards 2012 ·BMC Medical Informatics and Decision Making ·Gert van Valkenhoef,Tommi Tervonen,Bert de Brock,Hans L. Hillege	17
16	Culprit Vessel Only Versus Multivessel and Staged Percutaneous Coronary Intervention for Multivessel Disease in Patients Presenting With ST-Segment Elevation Myocardial Infarction 2011 ·Journal of the American College of Cardiology ·Pieter J. Vlaar,Karim D. Mahmoud,David R. Holmes,Gert van Valkenhoef,Hans L. Hillege,Iwan C.C. van der Horst,Felix Zijlstra,Bart J.G.L. de Smet	201
17	A stochastic multicriteria model for evidence‐based decision making in drug benefit‐risk analysis 2011 ·Statistics in Medicine ·Tommi Tervonen,Gert van Valkenhoef,Erik Buskens,Hans L. Hillege,Douwe Postmus	78
18	Multicriteria benefit–risk assessment using network meta-analysis 2011 ·Journal of Clinical Epidemiology ·Gert van Valkenhoef,Tommi Tervonen,Jing Zhao,Bert de Brock,Hans L. Hillege,Douwe Postmus	55
19	Algorithmic parameterization of mixed treatment comparisons 2011 ·Statistics and Computing ·Gert van Valkenhoef,Tommi Tervonen,Bert de Brock,Hans L. Hillege	26
20	OOPS: An S5n Prover for Educational Settings 2010 ·Electronic Notes in Theoretical Computer Science ·Gert van Valkenhoef,(unknown),Rineke Verbrugge	0

About Gert van Valkenhoef

Gert van Valkenhoef is a scholar working on Statistics, Probability and Uncertainty, Statistics and Probability and Experimental and Cognitive Psychology, having authored 33 papers that have together received 2.6k indexed citations. Recurring topics across this work include Meta-analysis and systematic reviews (11 papers), Statistical Methods in Clinical Trials (9 papers) and Health Systems, Economic Evaluations, Quality of Life (8 papers). The work is most often cited by research in Statistics, Probability and Uncertainty (325 citations), Statistics and Probability (319 citations) and Cardiology and Cardiovascular Medicine (366 citations). Gert van Valkenhoef has collaborated with scholars based in Netherlands, United Kingdom and United States. Frequent co-authors include A. E. Ades, Hans L. Hillege, Nicky J. Welton, Bert de Brock, Tommi Tervonen, Sofia Dias, Guobing Lu, Douwe Postmus, Orestis Efthimiou and Karel G.M. Moons. Their work appears in journals such as Journal of the American College of Cardiology, JNCI Journal of the National Cancer Institute and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact